Phase 3 Trial in gBRCA Breast Cancer Planned for 4Q 2013 SAN RAFAEL, Calif., May 16, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc.... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=310545Oncothyreon Announces Data for L-BLP25 and PX-866 to be Presented at American Society of Clinical Oncology Meeting Oncothyreon Inc. (MM)... ...
http://in.advfn.com/p.php?pid=nmona&article=57600521Merck KGaA (MKGAF) reported first quarter 2013 earnings per American Depositary Receipt (ADR) of $2.79, up 28.1% year over year. Revenues for the... ...
http://in.quote.com/news/zacksCache.aspx?id=704753Dr. Reddy's Laboratories (DRL), on Tuesday, reported a 66.58 per cent increase in net profit to Rs.570.9 crore for the fourth quarter of 2012-13... ...
http://www.thehindu.com/business/Industry/dr-reddys-lab-profit-up-18/article4715092.eceHigher prices for its multiple sclerosis treatment helped German pharmaceutical company Merck KGaA post a 54 percent rise in first-quarter net... ...
http://www.sify.com/finance/higher-prices-for-ms-drug-help-drug-firm-merck-news-health-nfoo4kihhdb.html